CSL Limited

OTC
CSLLY
Stock
Yield per half year: +19.38%
Dividend yield: 1.41%
Sector: Healthcare

CSL Limited

108.00108.0099.0099.0090.0090.0081.0081.0072.0072.0063.0063.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
36.26 54.97 -34.04% 48.2 -24.78%
P/S 6.52 5.01 30.28%
P/BV 4.94 5.89 -16.17%
P/FCF 57.35 28.5 101.24%
Ev/Ebitda 22.47 18.25 23.07%
Ev/S 7.24 4.62 56.61%
Ev/FCF 70.6 42.28 67.01%
E/P 0.0306 1.42 -97.84%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
32.22 23.27 38.44% 33.54 -3.94%
ROE 15.94 14.7 8.42%
ROA 7.11 7.42 -4.15%
ROIC 15.5 14.2 9.18%
ROS 17.99 11.61 54.92%
ROCE 19.56 17.11 14.33%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.57 2.95 -12.86% 2.65 -2.69%
Nеt Debt/Ebitda 2.22 0.0289 7590.31%
Debt/Ratio 0.3204 0.2166 47.94%
Debt/Equity 0.9598 1.1 -13.05%
Debt/Net Income 4.61 9.8 -52.97%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.53/10
1.41 1.72 -18.13% 1.19 +18.03%
Number of years of dividend growth 13 1.67 677.95%
DSI 1 0.7773 28.65%
Average dividend growth 9.55 -391.67 -102.44%
Average percentage for 5 years 1.19 3.28 -63.55%
Average percentage for payments 1688.6 159.36 959.63%
Difference from average difference in sector -0.3122

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
61.41 376.09 -83.67%
Growth impulse Ebitda in 5 years 50.59 370.25 -86.34%
Growth impulse Net Income in 5 years 25.63 281.12 -90.88%
Growth impulse FCF in 5 years 34.34 257.32 -86.65%
Growth impulse EPS in 5 years 17.69 476.32 -96.29%
IP Score
5.39/10

Similar companies

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription